starting over with new trial, page-5

Just not enough detail. I wonder just how advanced internally they really are and just when internally they changed direction and focus?. A lot of the core information exists, just depends how advanced FDA discussions are?? If all the FDA etc meetings have locked in a outline they may have significant areas covered after all we have had teh staff capable of that on board for a long time if if they haven't then what the ttruck have they been doing?. Dream tehy would be a year already in and have ticked a lot of boxes and now strategy has been released into the wild and to normal peasant shareholders , Erb has his incentive package locked in at the bottom so all upside . Could there be a upside surprise with a realistic timeline less than 3 years or are we back at day 1 start from scratch? Partner or dilution - a gun or knife decision?


Regardless of the actual device the management of business and trials has cost years and shareholder $ and burnt patent time. Disgusted